QA: Emergent BioSolutions Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367644_2023_Emergent_BioSolutions_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 227.75510204081633, 'aggregate_val': 1120900000, 'exp_sum': 4900000, 'exp_to_value': {'remainder_Revenues': 4900000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001367644, Emergent BioSolutions Inc.

  xvar xval
0 AssetsCurrent 1,210,700,000
1 IntangibleAssetsNetIncludingGoodwill 947,000,000
2 PropertyPlantAndEquipmentNet 817,600,000
3 remainder_Assets 191,300,000
4 LiabilitiesCurrent 1,229,900,000
5 LiabilitiesNoncurrent 481,900,000
6 remainder_Liabilities 71,800,000
7 CostOfGoodsAndServicesSold 693,700,000
8 SellingGeneralAndAdministrativeExpense 340,300,000
9 ResearchAndDevelopmentExpense 193,000,000
10 remainder_Expenses 68,700,000
11 remainder_Revenues 1,120,900,000
12 remainder_NetIncome -49,000,000
13 remainder_ComprehensiveNetIncome 19,200,000
  yvar yval
0 Assets 3,166,600,000
1 Liabilities 1,783,600,000
2 Expenses 1,295,700,000
3 Revenues 1,120,900,000
4 StockholdersEquity 1,383,000,000
5 NetIncome -223,800,000
6 ComprehensiveNetIncome -214,200,000
7 BaseVar 3,717,500,000
8 EconomicCapitalRatio 0.875

Edgar->Model Mapping

Feature Distribution

Change over Time